Well-woman visits: guidance and monitoring are key in this turning point for women's health.

The U.S. Department of Health and Human Services (HHS) adopted the Institute of Medicine’s recommendation that eight preventive services for women, including at least one annual well-woman visit (WWV), be included in the defined list of preventive care services providedwithout cost sharing under the Affordable Care Act (ACA, Section 2713; Institute of Medicine, 2011). WWVs are a key feature of the ACA’s prevention provision because they providewomenwith access to comprehensive, personalized, preventive services and a routine source of care for achieving health and wellness. Unfortunately, as U.S. health reforms progress under the ACA, guidance, education, and outreach associated with implementation of WWVs are lacking. Therefore, many women are unaware of the benefit. Similarly, providers are often unsure about what is covered. These crucial implementation issues jeopardize women’s access to key preventive care services. To address these gaps, the National Women’s Law Center (NWLC) and the Connors Center for Women’s Health and Gender Biology at Brigham andWomen’s Hospital (BWH), with funding provided by Pfizer, have developed resources for consumers, providers, and policymakers on WWVs to ensure that women are able to understand and access the preventive services now available to them under the ACA. For the ACA to be transformative for women’s health, its promise to remove cost barriers to WWVs must be realized fully. Removing the cost barrier for these important annual visits is particularly beneficial to women because they are impacted disproportionately by affordability challenges owing